CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies

) T and NK lymphocytes, we show that the CD7-edited T cells themselves can respond to viral peptides and therefore could be protective against pathogens. Hence, genomic disruption of a target antigen overcomes fratricide of CAR T cells and establishes the feasibility of using CD7 CAR T cells for the targeted therapy of T-cell malignancies.

CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies | Litlas